1. Home
  2. MEG vs EVO Comparison

MEG vs EVO Comparison

Compare MEG & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Montrose Environmental Group Inc.

MEG

Montrose Environmental Group Inc.

HOLD

Current Price

$22.14

Market Cap

930.8M

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.07

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEG
EVO
Founded
2012
1993
Country
United States
Germany
Employees
3500
4553
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
930.8M
1.1B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
MEG
EVO
Price
$22.14
$3.07
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$35.25
$7.00
AVG Volume (30 Days)
266.4K
47.1K
Earning Date
05-05-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
93.69
N/A
EPS
N/A
N/A
Revenue
$830,538,000.00
N/A
Revenue This Year
$5.41
$1.37
Revenue Next Year
$7.19
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
19.26
N/A
52 Week Low
$19.38
$2.31
52 Week High
$32.00
$4.42

Technical Indicators

Market Signals
Indicator
MEG
EVO
Relative Strength Index (RSI) 52.09 56.03
Support Level $20.80 $2.88
Resistance Level $23.48 $3.75
Average True Range (ATR) 0.79 0.07
MACD 0.13 0.01
Stochastic Oscillator 88.92 89.58

Price Performance

Historical Comparison
MEG
EVO

About MEG Montrose Environmental Group Inc.

Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits and permits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, and soil remediation. The company derives maximum revenue from United States.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: